Huai Lue An
Director/Board Member bei Guizhou Kekai Pharmaceutical Co., Ltd.
Vermögen: 52 Mio $ am 31.03.2024
Profil
Huai Lue An is currently a Director at Guizhou Kekai Pharmaceutical Co., Ltd.
Previously, he worked as a Chairman at Guizhou Xinbang Pharmaceutical Co., Ltd.
Bekannte Unternehmensbeteiligungen
Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
---|---|---|---|---|
30.09.2023 | 98 057 908 ( 86,31% ) | 52 Mio $ | 31.03.2024 | |
10.07.2023 | 670 ( 0,00% ) | 353 $ | 31.03.2024 |
Aktive Positionen von Huai Lue An
Unternehmen | Position | Beginn |
---|---|---|
Guizhou Kekai Pharmaceutical Co., Ltd.
Guizhou Kekai Pharmaceutical Co., Ltd. Medical DistributorsDistribution Services Part of Guizhou Xinbang Pharmaceutical Co., Ltd., Guizhou Kekai Pharmaceutical Co., Ltd. is a Chinese company that wholesales pharmaceutical products. The private company is based in Guiyang, China. The company was founded in 1995. Xue Feng Gu has been the CEO of the company since 2016. Guizhou Kekai Pharmaceutical Co. was acquired by Guizhou Xinbang Pharmaceutical Co., Ltd. on March 14, 2014 for $456.24 million. | Director/Board Member | - |
Ehemalige bekannte Positionen von Huai Lue An
Unternehmen | Position | Ende |
---|---|---|
GUIZHOU XINBANG PHARMACEUTICAL CO., LTD. | Chairman | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
GUIZHOU XINBANG PHARMACEUTICAL CO., LTD. | Health Technology |
Private Unternehmen | 1 |
---|---|
Guizhou Kekai Pharmaceutical Co., Ltd.
Guizhou Kekai Pharmaceutical Co., Ltd. Medical DistributorsDistribution Services Part of Guizhou Xinbang Pharmaceutical Co., Ltd., Guizhou Kekai Pharmaceutical Co., Ltd. is a Chinese company that wholesales pharmaceutical products. The private company is based in Guiyang, China. The company was founded in 1995. Xue Feng Gu has been the CEO of the company since 2016. Guizhou Kekai Pharmaceutical Co. was acquired by Guizhou Xinbang Pharmaceutical Co., Ltd. on March 14, 2014 for $456.24 million. | Distribution Services |